Develops prescription drugs for various diseases.
Jun 2026Revenue $8.22M/yrExpenses $94.5M/yr
No trendCash runway ≈ 1.5 years from Jun 2026
Figures by year
When will Aclaris Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $8.22M and expenses $94.5M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $7.83M | $84.2M | −$76.4M |
| Dec 2024 | $18.7M | $161M | −$142M |
| Dec 2023 | $31.2M | $129M | −$97.4M |
| Dec 2022 | $29.8M | $120M | −$89.9M |
| Dec 2021 | $6.76M | $96.5M | −$89.7M |
| Dec 2020 | $6.48M | $57.4M | −$50.9M |
| Dec 2019 | $4.23M | $115M | −$111M |
| Dec 2018 | $6.15M | $90.9M | −$84.8M |
| Dec 2017 | $1.68M | $56.0M | −$54.4M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.